Clinical Trials Browser

Interventional × Locally Advanced Rectal Cancer × XELOX × Clear all

NCT05086627 2024-08-22

Short-course Radiotherapy Followed by Tislelizumab + CapeOX in the Treatment for Locally Advanced Rectal Cancer

Phase 2 Completed

Gastrointestinal

Locally Advanced Rectal Cancer